Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) study: Protocol and baseline characteristics of a randomized controlled trial

Diamantidis, Clarissa J.; Bosworth, Hayden B.; Oakes, Megan; Davenport, Clemontina A.; Pendergast, Jane; Patel, Sonika; Moaddeb, Jivan; Barnhart, Huiman X.; Merrill, Peter; Baloch, Khaula; Crowley, Matthew J; Patel, Uptal D.

doi:10.1016/j.cct.2018.04.003

Cited by 18 publications

(17 citation statements)

References 57 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…STOP-DKD required a team-based approach to healthcare delivery, whereby PCPs fulfilled their usual care roles and research pharmacists interacted with study participants over the telephone for 36 months, delivering monthly behavioral-educational modules focused on home blood pressure monitoring, medication management, and diabetes self-management. 17 When clinically indicated, the two research pharmacists electronically made treatment recommendations to a participant's PCP based on evidence-based protocols. 17 These recommendations were based on participants' home-based blood pressure values.…”

Section: Study Design and Settingmentioning

confidence: 99%

“…17 When clinically indicated, the two research pharmacists electronically made treatment recommendations to a participant's PCP based on evidence-based protocols. 17 These recommendations were based on participants' home-based blood pressure values. Examples of research pharmacist recommendations are reported in Table 1.…”

Section: Study Design and Settingmentioning

confidence: 99%

“…Research staff collected three sets of blood pressure values (SBP, diastolic blood pressure, and mean arterial pressure) using Omron's Professional Digital Blood Pressure Monitor (Model HEM-907XL), following a standardized protocol. 17 This protocol specified that patients should rest for five minutes prior to blood pressure measurement.…”

Section: Study Design and Settingmentioning

confidence: 99%

“…The parent STOP-DKD trial randomized 281 participants, of which 138 were allocated to the intervention arm. 17 Previous reports of STOP-DKD have described participants' baseline characteristics and information regarding participants' ambulatory blood pressure measurements. 17,18 Our analysis was limited to participants for whom (1) the research pharmacist made at least one clinical recommendation to the PCP; (2) there were available data regarding the PCP's corresponding action; and (3) there were valid SBP measurements at both baseline and 36 months.…”

Section: Participantsmentioning

confidence: 99%

“…Details of the STOP-DKD approach have been previously described elsewhere. 17 STOP-DKD provided an innovative care delivery model, where pharmacists recommended medication-related changes to PCPs of patients with DKD. Since the central premise of STOP-DKD required communication-informed action between PCPs and pharmacists, the purpose of this analysis was to describe whether PCPs' acceptance of pharmacists' recommendations had an impact on systolic blood pressure (SBP) decline at 36 months.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Primary Care Providers’ Acceptance of Pharmacists’ Recommendations to Support Optimal Medication Management for Patients with Diabetic Kidney Disease

et al. 2019

Self Cite

View full text Add to dashboard Cite

Section: Study Design and Settingmentioning

confidence: 99%

Section: Study Design and Settingmentioning

confidence: 99%

Section: Study Design and Settingmentioning

confidence: 99%

Section: Participantsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Primary Care Providers’ Acceptance of Pharmacists’ Recommendations to Support Optimal Medication Management for Patients with Diabetic Kidney Disease

et al. 2019

Self Cite

View full text Add to dashboard Cite

Describing the delivery of clinical pharmacy services via telehealth: A systematic review

Melton

Jasmin

Johnson

et al. 2021

J Am Coll Clin Pharm

View full text Add to dashboard Cite

IntroductionTelehealth offers a promising opportunity for the delivery of clinical pharmacy services by increasing the accessibility of health care, extending the reach of clinical services, and allowing pharmacists to engage with patients who might otherwise be overlooked. The objectives of the project were to discover effective strategies for the delivery of clinical pharmacy services via telehealth and to identify core components of comprehensive medication management (CMM) that are deliverable via telehealth.MethodsA systematic literature review was performed by searching four databases (Cumulative Index to Nursing and Allied Health Literature [CINAHL], PubMed, Scopus, and Web of Science) for relevant citations using keywords and subject headings relating to telemedicine, clinical pharmacy services, and health conditions. Studies were eligible for inclusion in the review if the interventions they describe involved telehealth technologies and pharmacist care. Blind screening of abstracts and full‐text review was completed by six researchers divided into teams of two. Any discrepancies were resolved by the corresponding author.ResultsFifty‐nine studies met the inclusion criteria, most (n = 53) of which were conducted in the U.S. Five studies (8.5%) reported pharmacist training as an implementation strategy. The telehealth technologies most regularly utilized were telephone‐based interventions (n = 45), videoconferences (n = 13), and web‐based (n = 4) interventions, with five studies using a combination of technologies. Most studies focused on hypertension (n = 22), diabetes (n = 20), or lipid‐related (n = 14) disease state management. Eighteen studies qualified as CMM (n = 18), with most involving all five essential CMM functions.ConclusionThis systematic review study highlights opportunities for pharmacists to deliver clinical pharmacy services using telehealth. The majority of clinical pharmacy services described in the accessed literature was provided via telephone and focused on targeted monitoring of disease states. While studies reporting the use of CMM interventions were limited, there is an opportunity to increase the application of CMM principles as healthcare systems transition to providing more telehealth services.

show abstract

Optimising health outcomes via pharmacist delivered telehealth medicines management: a systematic review

Lowry

Kay

Marsom

et al. 2020

Pharmacy Practice and Res

View full text Add to dashboard Cite

Background: Pharmacist-led telehealth is an innovative service delivery model that may provide an alternative mode of care. It remains unclear how surrogate markers of health conditions differ when pharmacist services are delivered via telehealth compared to usual care. Aims: To assess if pharmacist-led telehealth interventions alter surrogate markers of health conditions. Methods: Pharmacist-led telehealth interventions compared to another active intervention for people using one or more regular medicines were included that reported surrogate markers of health conditions. Scopus, Embase, Medline and CINAHL were searched from inception to May 2020 to identify randomised controlled trials. Researchers screened articles to identify eligible studies, then data were extracted using a standardised data collection sheet. Quality assessment was undertaken using the Cochrane risk of bias tool. Data were reported as risk ratio and mean difference with corresponding 95% confidence intervals. Results: Of 1896 titles identified, 11 studies met the inclusion criteria. Telehealth interventions by pharmacists consisted of multifaceted interventions with contact over differing time durations. Some blood pressure and oral anticoagulation clinical outcomes were improved in the pharmacist-led telehealth group compared to the control group. However, the majority of outcomes were similar in both groups. Conclusion: This study identified that pharmacist-led telehealth interventions for a select range of chronic health conditions provides an acceptable adjunct to usual care and results in similar health outcomes for surrogate markers when compared to usual care.

show abstract

Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) study: Protocol and baseline characteristics of a randomized controlled trial

Abstract: NCT01829256.

Cited by 18 publications

References 57 publications

Primary Care Providers’ Acceptance of Pharmacists’ Recommendations to Support Optimal Medication Management for Patients with Diabetic Kidney Disease

Primary Care Providers’ Acceptance of Pharmacists’ Recommendations to Support Optimal Medication Management for Patients with Diabetic Kidney Disease

Describing the delivery of clinical pharmacy services via telehealth: A systematic review

Optimising health outcomes via pharmacist delivered telehealth medicines management: a systematic review

Contact Info

Product

Resources

About